ATE440150T1 - Oligonukleotide von für die oberflächenkomponente des ptlv-hüllproteins codierenden sequenzen und verwendungen davon - Google Patents
Oligonukleotide von für die oberflächenkomponente des ptlv-hüllproteins codierenden sequenzen und verwendungen davonInfo
- Publication number
- ATE440150T1 ATE440150T1 AT03746850T AT03746850T ATE440150T1 AT E440150 T1 ATE440150 T1 AT E440150T1 AT 03746850 T AT03746850 T AT 03746850T AT 03746850 T AT03746850 T AT 03746850T AT E440150 T1 ATE440150 T1 AT E440150T1
- Authority
- AT
- Austria
- Prior art keywords
- don
- ptlv
- viruses
- detecting
- terminus
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title abstract 3
- 241001529934 Simian T-lymphotropic virus 3 Species 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 8
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 108091093088 Amplicon Proteins 0.000 abstract 2
- 241000288906 Primates Species 0.000 abstract 2
- 208000000389 T-cell leukemia Diseases 0.000 abstract 2
- 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 abstract 2
- 206010042971 T-cell lymphoma Diseases 0.000 abstract 2
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 abstract 2
- 108010003533 Viral Envelope Proteins Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 210000004897 n-terminal region Anatomy 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 abstract 1
- 241000714259 Human T-lymphotropic virus 2 Species 0.000 abstract 1
- 241001466984 Simian T-lymphotropic virus 1 Species 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0205001A FR2838740A1 (fr) | 2002-04-22 | 2002-04-22 | Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations |
| PCT/FR2003/001274 WO2003088979A2 (fr) | 2002-04-22 | 2003-04-22 | Oligonucleotide issus des sequences codant pour la composante de surface de proteines d'enveloppe des virus des lymphomes / leucemies t chez les primates (ptlv) et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE440150T1 true ATE440150T1 (de) | 2009-09-15 |
Family
ID=28686243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03746850T ATE440150T1 (de) | 2002-04-22 | 2003-04-22 | Oligonukleotide von für die oberflächenkomponente des ptlv-hüllproteins codierenden sequenzen und verwendungen davon |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7507529B2 (de) |
| EP (1) | EP1497467B1 (de) |
| JP (1) | JP4541712B2 (de) |
| AT (1) | ATE440150T1 (de) |
| AU (1) | AU2003246850A1 (de) |
| CA (1) | CA2483327A1 (de) |
| DE (1) | DE60328880D1 (de) |
| ES (1) | ES2328130T3 (de) |
| FR (1) | FR2838740A1 (de) |
| WO (1) | WO2003088979A2 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040121335A1 (en) | 2002-12-06 | 2004-06-24 | Ecker David J. | Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections |
| WO2004060278A2 (en) | 2002-12-06 | 2004-07-22 | Isis Pharmaceuticals, Inc. | Methods for rapid identification of pathogens in humans and animals |
| US7666588B2 (en) | 2001-03-02 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy |
| US7226739B2 (en) | 2001-03-02 | 2007-06-05 | Isis Pharmaceuticals, Inc | Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations |
| US20030027135A1 (en) | 2001-03-02 | 2003-02-06 | Ecker David J. | Method for rapid detection and identification of bioagents |
| US7217510B2 (en) | 2001-06-26 | 2007-05-15 | Isis Pharmaceuticals, Inc. | Methods for providing bacterial bioagent characterizing information |
| FR2838740A1 (fr) * | 2002-04-22 | 2003-10-24 | Centre Nat Rech Scient | Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations |
| US8158354B2 (en) | 2003-05-13 | 2012-04-17 | Ibis Biosciences, Inc. | Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US7964343B2 (en) | 2003-05-13 | 2011-06-21 | Ibis Biosciences, Inc. | Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US8097416B2 (en) | 2003-09-11 | 2012-01-17 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US20120122096A1 (en) | 2003-09-11 | 2012-05-17 | Rangarajan Sampath | Compositions for use in identification of bacteria |
| US8546082B2 (en) | 2003-09-11 | 2013-10-01 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US8163895B2 (en) | 2003-12-05 | 2012-04-24 | Ibis Biosciences, Inc. | Compositions for use in identification of orthopoxviruses |
| US7666592B2 (en) | 2004-02-18 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for concurrent identification and quantification of an unknown bioagent |
| WO2005117270A2 (en) | 2004-05-24 | 2005-12-08 | Isis Pharmaceuticals, Inc. | Mass spectrometry with selective ion filtration by digital thresholding |
| US20050266411A1 (en) | 2004-05-25 | 2005-12-01 | Hofstadler Steven A | Methods for rapid forensic analysis of mitochondrial DNA |
| US7811753B2 (en) | 2004-07-14 | 2010-10-12 | Ibis Biosciences, Inc. | Methods for repairing degraded DNA |
| US8084207B2 (en) | 2005-03-03 | 2011-12-27 | Ibis Bioscience, Inc. | Compositions for use in identification of papillomavirus |
| EP1869180B1 (de) | 2005-03-03 | 2013-02-20 | Ibis Biosciences, Inc. | Zusammensetzung zur Verwendung bei der Identifikation von Polyomaviren |
| EP1904655A2 (de) | 2005-07-21 | 2008-04-02 | Isis Pharmaceuticals, Inc. | Verfahren zur raschen identifizierung und quantifizierung von nukleinsäurevarianten |
| US8088582B2 (en) | 2006-04-06 | 2012-01-03 | Ibis Biosciences, Inc. | Compositions for the use in identification of fungi |
| WO2008143627A2 (en) | 2006-09-14 | 2008-11-27 | Ibis Biosciences, Inc. | Targeted whole genome amplification method for identification of pathogens |
| JP5680304B2 (ja) | 2007-02-23 | 2015-03-04 | アイビス バイオサイエンシズ インコーポレイティッド | 迅速な法医学的ｄｎａ分析法 |
| WO2008151023A2 (en) | 2007-06-01 | 2008-12-11 | Ibis Biosciences, Inc. | Methods and compositions for multiple displacement amplification of nucleic acids |
| US8550694B2 (en) | 2008-09-16 | 2013-10-08 | Ibis Biosciences, Inc. | Mixing cartridges, mixing stations, and related kits, systems, and methods |
| EP2347254A2 (de) | 2008-09-16 | 2011-07-27 | Ibis Biosciences, Inc. | Probenverarbeitungseinheiten, -systeme und damit verbundene verfahren |
| EP2344893B1 (de) | 2008-09-16 | 2014-10-15 | Ibis Biosciences, Inc. | Mikroplatten-handhabungssysteme und verfahren |
| WO2010093943A1 (en) | 2009-02-12 | 2010-08-19 | Ibis Biosciences, Inc. | Ionization probe assemblies |
| WO2010104798A1 (en) | 2009-03-08 | 2010-09-16 | Ibis Biosciences, Inc. | Bioagent detection methods |
| US9393564B2 (en) | 2009-03-30 | 2016-07-19 | Ibis Biosciences, Inc. | Bioagent detection systems, devices, and methods |
| US8950604B2 (en) | 2009-07-17 | 2015-02-10 | Ibis Biosciences, Inc. | Lift and mount apparatus |
| WO2011008972A1 (en) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Systems for bioagent identification |
| WO2011014811A1 (en) | 2009-07-31 | 2011-02-03 | Ibis Biosciences, Inc. | Capture primers and capture sequence linked solid supports for molecular diagnostic tests |
| EP2462244B1 (de) | 2009-08-06 | 2016-07-20 | Ibis Biosciences, Inc. | Basiszusammensetzungen ohne massebestimmung zur nukleinsäureerkennung |
| EP3225695A1 (de) | 2009-10-15 | 2017-10-04 | Ibis Biosciences, Inc. | Multiple-displacement-amplifikation |
| US9758840B2 (en) | 2010-03-14 | 2017-09-12 | Ibis Biosciences, Inc. | Parasite detection via endosymbiont detection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0384566A3 (de) * | 1989-01-27 | 1991-11-13 | The Wistar Institute | Amplifikation von HTLV-I-Sequenzen von Patienten mit Multipler Sklerose |
| AU3219400A (en) | 1999-02-03 | 2000-08-25 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods and reagents for molecular detection of hiv-1 groups m, n and |
| FR2838740A1 (fr) * | 2002-04-22 | 2003-10-24 | Centre Nat Rech Scient | Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations |
-
2002
- 2002-04-22 FR FR0205001A patent/FR2838740A1/fr not_active Withdrawn
-
2003
- 2003-04-22 EP EP03746850A patent/EP1497467B1/de not_active Expired - Lifetime
- 2003-04-22 CA CA002483327A patent/CA2483327A1/fr not_active Abandoned
- 2003-04-22 WO PCT/FR2003/001274 patent/WO2003088979A2/fr not_active Ceased
- 2003-04-22 DE DE60328880T patent/DE60328880D1/de not_active Expired - Lifetime
- 2003-04-22 JP JP2003585731A patent/JP4541712B2/ja not_active Expired - Fee Related
- 2003-04-22 AU AU2003246850A patent/AU2003246850A1/en not_active Abandoned
- 2003-04-22 AT AT03746850T patent/ATE440150T1/de not_active IP Right Cessation
- 2003-04-22 ES ES03746850T patent/ES2328130T3/es not_active Expired - Lifetime
- 2003-04-22 US US10/512,340 patent/US7507529B2/en not_active Expired - Fee Related
-
2009
- 2009-02-10 US US12/368,600 patent/US7947452B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2838740A1 (fr) | 2003-10-24 |
| WO2003088979A3 (fr) | 2004-02-19 |
| EP1497467A2 (de) | 2005-01-19 |
| US20050287521A1 (en) | 2005-12-29 |
| WO2003088979A2 (fr) | 2003-10-30 |
| US7947452B2 (en) | 2011-05-24 |
| US20090186338A1 (en) | 2009-07-23 |
| AU2003246850A8 (en) | 2003-11-03 |
| DE60328880D1 (de) | 2009-10-01 |
| CA2483327A1 (fr) | 2003-10-30 |
| JP4541712B2 (ja) | 2010-09-08 |
| AU2003246850A1 (en) | 2003-11-03 |
| EP1497467B1 (de) | 2009-08-19 |
| ES2328130T3 (es) | 2009-11-10 |
| US7507529B2 (en) | 2009-03-24 |
| JP2005538696A (ja) | 2005-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE440150T1 (de) | Oligonukleotide von für die oberflächenkomponente des ptlv-hüllproteins codierenden sequenzen und verwendungen davon | |
| Hizi et al. | Characterization of mouse mammary tumor virus gag-pro gene products and the ribosomal frameshift site by protein sequencing. | |
| EP3319633B1 (de) | Impfstoff gegen rsv | |
| Hijikata et al. | Identification of new parvovirus DNA sequence in swine sera from Myanmar | |
| ES2234144T3 (es) | Analogos de peptidos inhibidores de la hepatitis c. | |
| PL1697507T3 (pl) | Zastosowanie białek i peptydów kodowanych przez genom nowego szczepu koronawirusa związanego z SARS | |
| JP2019501882A5 (de) | ||
| DE69534569D1 (de) | Hiv-1- und hiv-2-peptide zur hemmung von mit membranfusionen in zusammenhang stehenden phänomenen, einschliesslich der übertragung von hiv | |
| RU2492182C3 (ru) | ГИДРОФОБНЫЕ, МОДИФИЦИРОВАННЫЕ, ПОЛУЧЕННЫЕ ИЗ preS ВИРУСА ГЕПАТИТА В (HBV) ПЕПТИДЫ И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ПРОНИКНОВЕНИЯ HBV И HDV | |
| EA200702190A1 (ru) | Вакцинная композиция | |
| CN113286806A (zh) | 治疗压力、免疫反应和中风综合征的多肽 | |
| RU2012121884A (ru) | Варианты вируса гепатита с | |
| CN1488641A (zh) | 抑制sars冠状病毒的多肽药物及其衍生物和其应用 | |
| EP1613345A4 (de) | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 | |
| DK1417222T3 (da) | Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop | |
| Li et al. | A novel amino acid position in hemagglutinin glycoprotein of measles virus is responsible for hemadsorption and CD46 binding | |
| Schnölzer et al. | Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis | |
| JP6667432B2 (ja) | 遺伝子移入促進因子プロトランスズジン（Ｐｒｏｔｒａｎｓｄｕｚｉｎ）Ｂ | |
| WO1990000556A1 (en) | Synthetic hiv protease gene and method for its expression | |
| WO2006116763A3 (en) | Lawsonia intracellularis immunological proteins | |
| Tozser et al. | The protease of human T-cell leukemia virus type-1 is a potential therapeutic target | |
| PE20061441A1 (es) | Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia | |
| Li et al. | Total chemical synthesis of human T‐cell leukemia virus type 1 protease via native chemical ligation | |
| CN113583107B (zh) | CRIg功能区蛋白变体及其应用 | |
| EP3140317B1 (de) | Peptidinduzierte nk-zellen-aktivierung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |